Literature DB >> 8557385

Ciprofloxacin vs. cefotaxime regimens for the treatment of intra-abdominal infections.

J A Hoogkamp-Korstanje1.   

Abstract

The efficacy of ciprofloxacin plus metronidazole was compared with that of cefotaxime plus gentamicin plus metronidazole in 79 patients with proven intra-abdominal infections. Patients were classified with the Peritonitis Index Altona-II (PIA-II) score for severity of disease, underlying conditions, prognosis and type of infection. Local peritonitis was diagnosed in 21 patients, generalized peritonitis in 25, intra-abdominal abscesses in 33; 35 patients had polymicrobial infections. Cure and improvement rates were: ciprofloxacin 77%, cefotaxime combination 56% (p < 0.02). Failures were significantly associated with a low initial PIA-II score, the presence of generalized peritonitis or abscesses, persistence of pathogens and superinfection. Superinfection was observed in 49% of the cases under cefotaxime and in 30% under ciprofloxacin. Concentrations of ciprofloxacin in pus ranged 2.0-5.2 mg/l with simultaneous serum concentrations of 1.2-3.1 mg/l.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557385     DOI: 10.1007/bf01716286

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration.

Authors:  J S Solomkin; D L Hemsell; R Sweet; F Tally; J Bartlett
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

Review 2.  Intraabdominal infections.

Authors:  S L Gorbach
Journal:  Clin Infect Dis       Date:  1993-12       Impact factor: 9.079

3.  Peritoneal fluid concentrations of gentamicin in patients with spontaneous bacterial peritonitis.

Authors:  G D Richey; C J Schleupner
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections. Report from a Swedish Study Group.

Authors: 
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

Review 5.  Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infection. Joint Working Party of SIS North America and Europe.

Authors:  P O Nyström; R Bax; E P Dellinger; L Dominioni; W A Knaus; J L Meakins; C Ohmann; J S Solomkin; H Wacha; D H Wittmann
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

6.  Clinical comparison of cefotaxime with gentamicin plus clindamycin in the treatment of peritonitis and other soft-tissue infections.

Authors:  H H Stone; E S Morris; C E Geheber; L D Kolb; W E Dunlop
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

Review 7.  Treatment of intra-abdominal infections with quinolones.

Authors:  J A Smith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

8.  Reliability of criteria for predicting persistent or recurrent sepsis.

Authors:  H H Stone; A A Bourneuf; L D Stinson
Journal:  Arch Surg       Date:  1985-01
  8 in total
  3 in total

Review 1.  Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin.

Authors:  C E Nord
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

2.  Prognostic scores and design of clinical studies.

Authors:  C Ohmann
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

Review 3.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.